Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Duleipo AB
AB
Active
Org 5592428782
Forskningsringen 19, 174 62
Sundbyberg
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2020 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Duleipo AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
WK
Wael Khedayier Yassir
Chief Executive Officer
Chief Executive Officer
2025
Former (1)
LA
Leith Abdul Wahid Yassir
Chief Executive Officer
Chief Executive Officer
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LY
Lilas Yassir
Deputy Board Member
Deputy Board Member
2025
WK
Wael Khedayier Yassir
Board of Directors
Board of Directors
2025
Former (3)
FJ
Faouaz Jasim Badawi
Board of Directors
Board of Directors
2020 – 2025
LA
Leith Abdul Wahid Yassir
Board of Directors
Board of Directors
2020 – 2020
MB
Maryam Badavi
Deputy Board Member
Deputy Board Member
2020 – 2025
Shareholders
As of last annual report
Wael Smith AB — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Wael Smith AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Duleipo AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network